NCT07231237

Brief Summary

This research study is looking at the safety and effectiveness of Solventum™ Vitrebond™ Pulp Protect Liner/Base for direct pulp capping (DPC) on permanent teeth that have pulp exposure due either to deep cavities, trauma, or other accidental causes. Dental pulp is the part of the tooth that contains the nerves, blood vessels, and cells that keep teeth healthy. The DPC procedure is done by dentists to help preserve tooth health if there is pulp exposure during the tooth restoration or due to trauma. Participants must have at least one permanent tooth with pulp exposure that needs DPC to be eligible for the study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 17, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

February 17, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2026

Completed
Last Updated

May 6, 2026

Status Verified

May 1, 2026

Enrollment Period

2 months

First QC Date

November 13, 2025

Last Update Submit

May 5, 2026

Conditions

Keywords

dentalcariescavitiespulp exposuredirect pulp cappingVitrebond Pulp Protectpulp vitalitydentin bridgepulp protection

Outcome Measures

Primary Outcomes (1)

  • Pulp Vitality at 1-year

    Pulp vitality, assessed by pulp sensibility testing using a refrigerant spray intended for dental use. A positive response from the pulp sensibility test is indicative of the pulp vitality of the tooth (primary endpoint). Categories for pulp vitality will include: 1. Vital pulp (normal): Positive response from the pulp sensibility test that subsides within 5 seconds. 2. Reversible pulpitis: Positive response from pulp sensibility test that lasts greater than 5 seconds up to approximately 30 seconds. 3. Irreversible pulpitis: Prolonged positive response from pulp sensibility test that lasts more than approximately 30 seconds. 4. Non-vital pulp: Negative response from the pulp sensibility test.

    1 year post-restoration

Secondary Outcomes (8)

  • Pulp Vitality at baseline, 3 months, 6 months, and 2, 3, 4, and 5 years

    Baseline, 3 months, 6 months, and 2, 3, 4, and 5 years post-restoration.

  • Reparative dentin formation

    6 months and 1 year, and only if taken at the 2-, 3-, 4-, and 5-year post-restoration

  • Apical periodontitis

    6-months and 1-year post-restoration, and at 2-, 3-, 4-, and 5-years post-restoration if periapical radiographs are taken

  • Internal root resorption

    6 months and 1 year, and if taken at the 2-, 3-, 4-, and 5-years post-restoration

  • External root resorption

    6 months and 1 year, and if taken at the 2-, 3-, 4-, and 5-years post-restoration

  • +3 more secondary outcomes

Study Arms (1)

Vitrebond™ Pulp Protect Liner/Base

EXPERIMENTAL

Vitrebond™ Pulp Protect Liner/Base used for Direct Pulp Capping

Device: Vitrebond™ Pulp Protect Liner/Base

Interventions

Vitrebond™ Pulp Protect Liner/Base used for Direct Pulp Capping

Vitrebond™ Pulp Protect Liner/Base

Eligibility Criteria

Age7 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is age 7 years or older at time of consent.
  • Subject is in good general health (i.e., meets American Society of Anesthesiologists (ASA) Level I or ASA Level II classification criteria).
  • Subject or Subject's Legally Authorized Representative is able and willing to understand and sign an Informed Consent Form or give Assent, as applicable.
  • Subject is able and willing to return in-person for all scheduled study visits.
  • Subject is able and willing to follow study restrictions.
  • Subject has existing dental radiographic images of the study teeth of current and acceptable diagnostic quality taken within 3 months of tooth restoration.
  • Study tooth has healthy periodontal tissues or mildly inflamed tissues not associated with trauma, with probing depths no greater than 4 mm and no gingival recession associated with self-reported sensitivity.
  • Study tooth has no pre-operative sensitivity or exhibit pre-operative sensitivity that is relieved immediately after stimulus removal.
  • Study tooth has a positive response to a sensibility test (i.e., cold test using a refrigerant spray).
  • Study tooth can be restored with a direct permanent restoration (stepwise caries removal will not be used).
  • Study teeth are on opposite right/left sides of the mouth (for Subjects with more than one candidate study tooth).
  • Study tooth will be restored no later than 1 month after the date of the first study tooth's restoration (for Subjects with more than one candidate study tooth).
  • Subject has one or more permanent teeth with pinpoint pulpal exposure (0.5 mm - 1.0 mm in diameter) needing direct pulp capping, excluding third molars.

You may not qualify if:

  • Subject has a history of adverse reaction to any materials used in this study, including but not limited to acrylates.
  • Subject is unable, for any reason, to tolerate the study procedures (e.g., use of a rubber dam) or the length of time required to complete the restoration(s) on the study tooth/teeth.
  • Subject is taking part in or planning to be enrolled in a clinical evaluation of any other dental materials at any time during the study.
  • Subject has a history of chronic use of anti-inflammatory, analgesic (pain), and/or mind-altering drugs for medical (including psychiatric) and pharmacotherapeutic therapies that might alter perception of pain.
  • Subject is pregnant or breast feeding at the time of screening.
  • Subject has any spontaneous or other orofacial pain (excluding pain from trauma cases, which may exhibit spontaneous pain due to tooth fracture) within the same quadrant as the study tooth that may interfere with assessment of sensitivity.
  • Study tooth diagnosed with cracked tooth syndrome.
  • Study tooth mobility \>= grade 2 using the Miller's tooth mobility index.
  • Study tooth has previous and current signs and symptoms of pulpal and/or periapical disease (e.g., root resorption or pulpal calcifications) or irreversible pulpitis (excluding pain from trauma cases).
  • Study tooth has no systemic mineralization pathology (e.g., amelogenesis imperfecta, enamel hypoplasia, etc.)
  • Study tooth that is not restorable
  • Study tooth that requires a crown preparation.
  • Study tooth has an existing restoration or requires a new restoration that interferes with radiographic assessments (e.g., caries on the buccal surface).
  • Study tooth exhibits bleeding of the exposed pulp that does not stop within 8 minutes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts University

Boston, Massachusetts, 02111, United States

Location

Related Publications (1)

  • Miller, S.C, Textbook of periodontia, Blakiston Company, Philidelphia, 1938

    BACKGROUND

MeSH Terms

Conditions

Dental CariesDental Pulp Exposure

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic DiseasesDental Pulp Diseases

Study Officials

  • Mabi Singh, DMD, BDS, MS

    Tufts University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Multi-site, single arm clinical study
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2025

First Posted

November 17, 2025

Study Start

February 17, 2026

Primary Completion

April 15, 2026

Study Completion

April 15, 2026

Last Updated

May 6, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations